Solazyme Announces Appointment of Former DuPont CFO Gary Pfeiffer to the Board of Directors

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--

Solazyme, Inc. SZYM today announced that former E.I. du Pont de Nemours and Company (DuPont) CFO Gary Pfeiffer has joined the Solazyme Board of Directors. Mr. Pfeiffer has also joined Solazyme's Audit Committee. Current Board member and Audit Committee Chair Ann Mather has informed the Company that she intends to transition her responsibilities as Audit Committee Chair to Mr. Pfeiffer and thereafter resign as Audit Committee Chair and director of the Company prior to the end of 2014.

“We are truly excited to be welcoming Gary to the Board. His experience at DuPont in international operations, large-scale manufacturing, biosciences and strategic planning makes him a perfect addition to guide us through this next phase of commercialization,” said Jerry Fiddler, Solazyme Chairman of the Board. “On behalf of the entire Board I want to extend our sincere gratitude to Ann for her tireless work for Solazyme. Her advice and counsel have been key in guiding the Company through a critical period of strategic and commercial development.”

Over the course of his 32-year career at DuPont, Gary Pfeiffer had extensive senior executive experience in global corporate finance, accounting, international operations, and strategic planning across a multinational corporation operating in complex industries including industrial biotechnology. During his nine years as Chief Financial Officer of DuPont, he oversaw a significant re-engineering of the portfolio that generated over $50 billion in divestitures and acquisitions including an enhanced focus on biosciences. Earlier in his career, he held numerous finance positions at both the corporate and business unit level, including three years in Brazil and four years in Japan, as well as leadership positions in manufacturing and information systems. Under Mr. Pfeiffer's leadership, DuPont also became a best practice leader in environmental sustainability as a way to increase shareholder value.

Mr. Pfeiffer will be joining current Board members Michael Arbige, Vice President, Research and Development, DuPont Industrial Biosciences; Ian Clark, CEO of Genentech; James Craigie, Chairman and CEO of Church & Dwight Co.; Chairman Jerry Fiddler, former CEO and founder of Wind River Systems; Peter Kovacs, former President and CEO of NutraSweet Kelco; Ann Mather, former CFO of Pixar and current board member of Google, MGM Holdings Inc., and Netflix; and Jonathan Wolfson, CEO and co-founder of Solazyme.

About Solazyme, Inc.

Solazyme, Inc. (SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources – petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into four target markets: (1) fuels and chemicals, (2) nutrition, (3) oil field services and (4) consumer products.

Solazyme®, the Solazyme logo and other trademarks or service names are trademarks of Solazyme, Inc.